Cerebral electrostimulation (CES) as a treatment for migraine headache was investigated. Eighteen participants recorded data on headaches for two baseline weeks. Six were assigned to each of three groups--an active treatment group receiving CES, a placebo group receiving a simulated version of CES, and a no-treatment control group placed on a waiting list during the study. The CES group evidenced a significant reduction in headache duration and intensity relative to the placebo group. The waiting list control group did as well as the CES group. A number of hypotheses were put forth in an attempt to account for the unexpected finding.